Randall C. Schatzman
Chief Executive Officer at Bolt Biotherapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Bolt Biotherapeutics Inc., 3 years.
Chief executive roles
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 6, 2023 | Bolt Biotherapeutics Inc. | Open-market purchase | +2,500 | $0.78 | $1,950 |
| Jun 6, 2023 | Bolt Biotherapeutics Inc. | Open-market purchase | +2,500 | $1.18 | $2,950 |
| Dec 6, 2022 | Bolt Biotherapeutics Inc. | Open-market purchase | +2,500 | $1.18 | $2,950 |
| Jun 6, 2022 | Bolt Biotherapeutics Inc. | Open-market purchase | +2,500 | $1.64 | $4,100 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.